An 18-Month Comparison of Clinical Outcomes Between Continuous-Flow Left Ventricular Assist Devices [1]
The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.
Source name:
European Journal of Cardio-Thoracic Surgery
Resource link:
Subspecialty(ies):
Cardiac [4]
Taxonomy2018 vocabulary term reference: